AACE Rare Endocrine Disease Series is pleased to present Fatigue, Abnormal Body Composition and Bone Loss: Is Adult GHD to Be Blamed? This course is designed to help clinicians create a path to diagnosis when encountering a patient with growth hormone deficiency.
This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The course will provide clinicians with the latest evidence-based guidelines, algorithms, consensus statements, and educational resources for diagnosing, managing, and treating these conditions. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.
Upon completion of the program, participants will be able to:
Planner Disclosures
Kevin Yuen, MD, FACE: Ascendis: Research Funding, Consultant; Corcept: Research Funding; Chiesi: Research Funding, Consultant; Crinetics: Research Funding, Consultant; Neurocrine: Consultant; Novo Nordisk: Speakers’ Bureau, Consultant; Recordati: Speakers’ Bureau, Consultant; Sparrow: Research Funding
Chris Yedinak, DNP: No relationships to disclose
Amy Ogunsunlade: No relationships to disclose
Faculty Disclosures
Chris Yedinak, DNP: No relationships to disclose All of the relevant financial relationships listed for these individuals have been mitigated